TWI221156B - Antithrombotic compounds - Google Patents

Antithrombotic compounds Download PDF

Info

Publication number
TWI221156B
TWI221156B TW088109931A TW88109931A TWI221156B TW I221156 B TWI221156 B TW I221156B TW 088109931 A TW088109931 A TW 088109931A TW 88109931 A TW88109931 A TW 88109931A TW I221156 B TWI221156 B TW I221156B
Authority
TW
Taiwan
Prior art keywords
alkyl
compound
please read
scope
before filling
Prior art date
Application number
TW088109931A
Other languages
English (en)
Chinese (zh)
Inventor
Johannes Egbertus Maria Basten
Boeckel Constant Adriaan A Van
Rogier Christian Buijsman
Cornelia Maria Dreef-Tromp
Original Assignee
Akzo Nobel Nv
Univ Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv, Univ Leiden filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of TWI221156B publication Critical patent/TWI221156B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
TW088109931A 1998-06-17 1999-06-14 Antithrombotic compounds TWI221156B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98202037 1998-06-17

Publications (1)

Publication Number Publication Date
TWI221156B true TWI221156B (en) 2004-09-21

Family

ID=8233825

Family Applications (1)

Application Number Title Priority Date Filing Date
TW088109931A TWI221156B (en) 1998-06-17 1999-06-14 Antithrombotic compounds

Country Status (31)

Country Link
US (1) US6486129B1 (es)
EP (1) EP1087992B1 (es)
JP (1) JP4369052B2 (es)
KR (1) KR100790910B1 (es)
CN (1) CN1261450C (es)
AR (1) AR019674A1 (es)
AT (1) ATE405580T1 (es)
AU (1) AU756493B2 (es)
BR (1) BR9911300A (es)
CA (1) CA2334863C (es)
CO (1) CO5080750A1 (es)
CY (1) CY1108567T1 (es)
CZ (1) CZ299382B6 (es)
DE (1) DE69939378D1 (es)
DK (1) DK1087992T3 (es)
ES (1) ES2312210T3 (es)
HK (1) HK1034266A1 (es)
HU (1) HU229088B1 (es)
ID (1) ID26614A (es)
IL (2) IL139955A0 (es)
NO (1) NO326057B1 (es)
NZ (1) NZ508623A (es)
PE (1) PE20000700A1 (es)
PL (1) PL199433B1 (es)
PT (1) PT1087992E (es)
RU (1) RU2225869C2 (es)
SK (1) SK286755B6 (es)
TR (1) TR200003710T2 (es)
TW (1) TWI221156B (es)
WO (1) WO1999065934A1 (es)
ZA (1) ZA200007075B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2334863C (en) * 1998-06-17 2011-02-15 Akzo Nobel Nv Antithrombotic compounds
TWI289566B (en) 1999-12-07 2007-11-11 N.V.Organon Antithrombotic compound
DE10049937A1 (de) * 2000-10-06 2002-04-11 Knoll Ag Niedermolekulare Inhibitoren von Serinproteasen mit Polyhydroxyalkyl- und Polyhydroxycycloalkylresten
BR0307266A (pt) * 2002-01-31 2004-12-07 Morphochem Ag Komb Chemie Compostos que inibem a atividade do fator xa
DE10300049A1 (de) * 2003-01-03 2004-07-15 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Faktor VIIa inhibieren
DE10330900B4 (de) * 2003-07-01 2006-09-14 Leibniz-Institut Für Polymerforschung Dresden E.V. Biomaterial mit einem modularen Beschichtungssystem zur Anwendung in Medizinprodukten mit direktem Blutkontakt
EP1574516A1 (en) * 2004-03-05 2005-09-14 Sanofi-Aventis Antithrombotic compound
TW200621794A (en) * 2004-10-06 2006-07-01 Akzo Nobel Nv Pulmonary administration of an antithrombotic compound
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) * 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
ES2362011T3 (es) * 2005-10-10 2011-06-27 N.V. Organon Inhibidores duales antitrombóticos anticoagulantes que comprenden una marca de biotina.
US20090111769A1 (en) * 2005-10-10 2009-04-30 De Kort Martin Antithrombotic Compound
EP2421878B1 (en) * 2008-10-03 2017-06-14 Glycan Biosciences LLC Anionic oligosaccharide conjugates
CN114423785A (zh) 2019-07-01 2022-04-29 通尼克斯制药有限公司 抗-cd154抗体及其用途
MX2023008055A (es) 2021-01-06 2023-08-22 Tonix Pharma Ltd Métodos para inducir tolerancia inmune con anticuerpos anti-cd154 modificados.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT84170B (pt) * 1986-01-24 1989-03-30 Sanofi Sa Processo para a preparacao de derivados n alfa-substituidos das n alfa-aril-sulfonilaminoacil d-amidinofenil-alaninamidas
DE4115468A1 (de) 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
DE4206858A1 (de) * 1992-03-05 1993-09-09 Behringwerke Ag Glycopeptid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
EP0649854B1 (en) * 1993-09-01 2000-03-15 Akzo Nobel N.V. Bisconjugates comprising two saccharides and a spacer
IL120722A (en) * 1996-05-08 1999-07-14 Akzo Nobel Nv Polysulfated tetrasaccharide derivatives and pharmaceutical compositions containing them
CA2334863C (en) * 1998-06-17 2011-02-15 Akzo Nobel Nv Antithrombotic compounds

Also Published As

Publication number Publication date
PE20000700A1 (es) 2000-08-14
AR019674A1 (es) 2002-03-13
DE69939378D1 (de) 2008-10-02
HUP0102764A2 (hu) 2001-12-28
KR100790910B1 (ko) 2008-01-03
ATE405580T1 (de) 2008-09-15
PL199433B1 (pl) 2008-09-30
CZ20004735A3 (cs) 2001-08-15
ZA200007075B (en) 2002-02-28
DK1087992T3 (da) 2008-11-24
ID26614A (id) 2001-01-25
IL139955A0 (en) 2002-02-10
HUP0102764A3 (en) 2003-11-28
AU756493B2 (en) 2003-01-16
KR20010052943A (ko) 2001-06-25
CA2334863C (en) 2011-02-15
CN1261450C (zh) 2006-06-28
EP1087992B1 (en) 2008-08-20
HK1034266A1 (en) 2001-10-19
SK19222000A3 (sk) 2001-07-10
CO5080750A1 (es) 2001-09-25
CA2334863A1 (en) 1999-12-23
CN1305494A (zh) 2001-07-25
BR9911300A (pt) 2001-04-03
NO326057B1 (no) 2008-09-08
JP2002518407A (ja) 2002-06-25
NO20006317D0 (no) 2000-12-12
PL345238A1 (en) 2001-12-03
NZ508623A (en) 2002-11-26
RU2225869C2 (ru) 2004-03-20
HU229088B1 (en) 2013-07-29
SK286755B6 (sk) 2009-05-07
JP4369052B2 (ja) 2009-11-18
PT1087992E (pt) 2008-10-17
CZ299382B6 (cs) 2008-07-09
EP1087992A1 (en) 2001-04-04
NO20006317L (no) 2001-02-14
CY1108567T1 (el) 2014-04-09
ES2312210T3 (es) 2009-02-16
WO1999065934A1 (en) 1999-12-23
US6486129B1 (en) 2002-11-26
TR200003710T2 (tr) 2001-04-20
IL139955A (en) 2006-08-20
AU4512999A (en) 2000-01-05

Similar Documents

Publication Publication Date Title
TWI221156B (en) Antithrombotic compounds
TW492957B (en) N-substituted 2-cyanopyrrolidnes
FI111726B (fi) Menetelmä terapeuttisesti käyttökelpoisten sulfatoitujen glykosaminoglykaanijohdannaisten valmistamiseksi
JP2015164947A (ja) 新規硫酸化オリゴ糖誘導体
US6271342B1 (en) Sugar-modified cytostatics
HU227451B1 (en) 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block and pharmaceutical compositions containing them
JP5632886B2 (ja) ビオチン残基を含む抗血栓性デュアルインヒビター
JP3918953B2 (ja) ２個の糖とスペーサーとを含んでなる二結合体
TW498078B (en) Carbohydrate derivatives
JPH05247078A (ja) 糖化合物、シアル酸含有糖鎖類生合成阻害剤、その製造方法、並びに新規な中間体
US20190256503A1 (en) Lls compounds for treatment of cancer
EP3981777A1 (en) Antiviral compounds and polymers
MXPA00012554A (es) Compuestos antitromboticos
US20110212907A1 (en) Hexadecasaccharides with antithrombotic activity, including a covalent bond and an amino chain
JPH05194518A (ja) ６−メルカプトプリン誘導体及びその製法
JP2001220351A (ja) 抗潰瘍剤

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees